Estrogen plus progestin increased lung cancer mortality but not incidence in postmenopausal women

Johnson, Bruce E.; Johnson, Cynda A.
February 2010
ACP Journal Club;2/16/2010, Vol. 152 Issue 2, p7
Academic Journal
The article presents information on a study to examine whether a combination of estrogen and progestin increase lung cancer mortality in postmenopausal women. A study was conducted on 16 608 postmenopausal women between 50 to 79 years of age with an intact uterus. It was found that in postmenopausal women, estrogen combined with progestin increased lung cancer mortality but not incidence.


Related Articles

  • Comparison of postmenopausal endogenous sex hormones among Japanese, Japanese Brazilians, and non-Japanese Brazilians. Iwasaki, Motoki; Kasuga, Yoshio; Yokoyama, Shiro; Onuma, Hiroshi; Nishimura, Hideki; Kusama, Ritsu; Hamada, Gerson Shigeaki; Nishimoto, Ines Nobuko; Maciel, Maria do Socorro; Motola, Jr., Juvenal; Laginha, Fábio Martins; Anzai, Roberto; Tsugane, Shoichiro // BMC Medicine;2011, Vol. 9 Issue 1, p16 

    Background: Differences in sex hormone levels among populations might contribute to the variation in breast cancer incidence across countries. Previous studies have shown higher breast cancer incidence and mortality among Japanese Brazilians than among Japanese. To clarify the difference in...

  • Age-related changes in sex steroid levels influence bone mineral density in healthy Indian men. Venkat, K.; Desai, M.; Arora, M. M.; Singh, P.; Khatkhatay, M. I. // Osteoporosis International;Jun2009, Vol. 20 Issue 6, p955 

    Age-related changes in sex steroid levels and its contribution to variations in rate of bone loss among men is unclear. Although, Bio-T and Bio-E2 levels declined with age and depicted an association with BMD in healthy Indian men, Bio-E2 was found to be an independent predictor of BMD....

  • Estrogen levels and breast cancer risk.  // Geriatrics;Mar1991, Vol. 46 Issue 3, p19 

    The article reports that two recent studies associate estrogen use with at least a modest increase in breast cancer risk. In one, researchers at the University of Southern California School of Medicine, Los Angeles, concluded that higher estrogen levels may help account for a sixfold greater...

  • Mixed Epithelial and Stromal Tumors of the Kidney. Mohanty, Sambit K.; Parwani, Anil V. // Archives of Pathology & Laboratory Medicine;Sep2009, Vol. 133 Issue 9, p1483 

    Mixed epithelial and stromal tumor of the kidney is a recently recognized distinct neoplasm that should be distinguished from other renal neoplasms. These tumors are relatively rare with a female preponderance. Imaging studies are not diagnostic but reveal a solid or solid and cystic mass in...

  • Consumption of Lactobacillus acidophilus and Bifidobacterium longum Does Not Alter Phytoestrogen Metabolism and Plasma Hormones in Men: A Pilot Study. McMullen, Mary H.; Hamilton-Reeves, Jill M.; Bonorden, Melissa J.L.; Wangen, Kerry E.; Phipps, William R.; Feirtag, Joellen M.; Kurzer, Mindy S. // Journal of Alternative & Complementary Medicine;Nov2006, Vol. 12 Issue 9, p887 

    Objective: The aim of this study was to determine whether equol excretion status and plasma hormone and leptin concentrations can be influenced by consumption of a probiotic supplement. A secondary focus was to investigate whether male equol excretors have a hormone profile consistent with...

  • Symptom Experience After Discontinuing Use of Estrogen Plus Progestin. Ockene, Judith K.; Barad, David H.; Cochrane, Barbara B.; Larson, Joseph C.; Gass, Margery; Wassertheil-Smoller, Sylvia; Manson, JoAnn E.; Barnabei, Vanessa M.; Lane, Dorothy S.; Brzyski, Robert G.; Rosal, Milagros C.; Wylie-Rosett, Judy; Hays, Jennifer // JAMA: Journal of the American Medical Association;7/13/2005, Vol. 294 Issue 2, p183 

    Context Little is known about women’s experiences after stopping menopausal hormone therapy. Objective To describe women’s symptoms and management strategies after stopping the intervention in a large estrogen plus progestin trial. Design, Setting, and Participants Cross-sectional...

  • Research brief: Combined HRT trebles DVT risk.  // GP: General Practitioner;5/27/2005, p5 

    The article reports that women on combined HRT are three times more likely to develop DVT than women not taking HRT, Researchers found that oestrogen-only HRT did not significantly increase the risk. The study included 95 women who had idiopathic DVT and 610 women without DVT and no DVT risk...

  • MINERVA.  // BMJ: British Medical Journal (International Edition);9/10/94, Vol. 309 Issue 6955, p680 

    Reports several topics related to medicine. Prevalence in early appearance of lung cancer between men and women; Steroid hormones not licensed in Japan; Studies on childhood leukemia; Admission of scalded children in the burns unit in ST. Lawrence Hospital, Chepstow.

  • Association of sulfotransferase SULT1A1 with breast cancer risk: a meta-analysis of case-control studies with subgroups of ethnic and meonpausal statue. Yiwei Jiang; Liheng Zhou; Tingting Yan; Zhenzhou Shen; Zhimin Shao; Jinsong Lu // Journal of Experimental & Clinical Cancer Research (17569966);2010, Vol. 29, p101 

    Background: Sulfotransferase (SULT) plays an important role in the formation of estrogen which is usually conferred as a risk factor for breast cancer. Polymorphism of the SULT1A1 may be closely associated with breast cancer. However, studies on the association between polymorphism and breast...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics